Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
Antimalarial drugs have usually been first deployed in areas of malaria endemicity at doses which were too low, particularly for high-risk groups such as young children and pregnant women. This may accelerate the emergence and spread of resistance, thereby shortening the useful life of the drug, but...
Hlavní autor: | White, N |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2013
|
Podobné jednotky
-
Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
Autor: Banda, CG, a další
Vydáno: (2024) -
Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
Autor: Kloprogge, F
Vydáno: (2013) -
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
Autor: Tarning, J, a další
Vydáno: (2014) -
Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
Autor: Tarning, J, a další
Vydáno: (2014) -
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
Autor: White, N
Vydáno: (1997)